United Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$513K Sell
1,044
-57
-5% -$30.9K 0.06% 282
2025
Q4
$638K Sell
1,101
-61
-5% -$34.5K 0.08% 244
2025
Q3
$564K Buy
1,162
+453
+64% +$211K 0.08% 244
2025
Q2
$287K Buy
709
+215
+44% +$89.9K 0.05% 322
2025
Q1
$246K Sell
494
-139
-22% -$75.3K 0.05% 307
2024
Q4
$329K Sell
633
-68
-10% -$37.4K 0.07% 278
2024
Q3
$434K Buy
701
+250
+55% +$148K 0.1% 213
2024
Q2
$249K Buy
+451
New +$258K 0.08% 228

Other funds holding TMO

United Advisor Group's TMO Position: Q1 2026 in Review

United Advisor Group reduced its Thermo Fisher Scientific (TMO) stake by 5.2% in Q1 2026, selling an estimated $30.9K and leaving 1,044 shares worth $513K. The position accounts for 0.06% of the portfolio, ranked #282.

United Advisor Group first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. The position peaked at $638K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • United Advisor Group held 1,044 shares of Thermo Fisher Scientific worth $513K as of Q1 2026.
  • United Advisor Group sold 57 Thermo Fisher Scientific shares in Q1 2026, an estimated $30.9K.
  • Thermo Fisher Scientific made up 0.06% of United Advisor Group's portfolio in Q1 2026, its #282 holding.
  • United Advisor Group first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
  • United Advisor Group's Thermo Fisher Scientific position peaked at $638K in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.